Authors
Kristel Paque, Robert Vander Stichele, Monique Elseviers, Koen Pardon, Tinne Dilles, Luc Deliens, Thierry Christiaens
Publication date
2019/1
Source
Palliative medicine
Volume
33
Issue
1
Pages
37-48
Publisher
SAGE Publications
Description
Background
Knowing the barriers/enablers to deprescribing in people with a life-limiting disease is crucial for the development of successful deprescribing interventions. These barriers/enablers have been studied, but the available evidence has not been summarized in a systematic review.
Aim
To identify the barriers/enablers to deprescribing of medications in people with a life-limiting disease.
Design
Systematic review, registered in PROSPERO (CRD42017073693).
Data sources
A systematic search of MEDLINE, Embase, Web of Science and CENTRAL was conducted and extended with a hand search. Peer-reviewed, primary studies reporting on barriers/enablers to deprescribing in the context of explicit life-limiting disease were included in this review.
Results
A total of 1026 references were checked. Five studies met the criteria and were included in this review. Three types of barriers/enablers were found …
Scholar articles
K Paque, R Vander Stichele, M Elseviers, K Pardon… - Palliative medicine, 2019